INTRODUCTION: Chronic kidney disease (CKD) is increasingly recognised as a growing global public health problem. Early detection and management can significantly reduce the loss of kidney function. The proposed trial aims to evaluate the impact of a community pharmacy-led intervention combining CKD screening and medication review on CKD detection and quality use of medicines (QUM) for patients with CKD. We hypothesise that the proposed intervention will enhance detection of newly diagnosed CKD cases and reduce potentially inappropriate medications use by people at risk of or living with CKD. METHODS AND ANALYSIS: This study is a multicentre, pragmatic, two-level cluster randomised controlled trial which will be conducted across different regions in Australia. Clusters of community pharmacies from geographical groups of co-located postcodes will be randomised. The project will be conducted in 122 community pharmacies distributed across metropolitan and rural areas. The trial consists of
1. This large cohort study found that in the general population, a higher self-reported frequency of adding salt to foods was significantly associated with increased chronic kidney disease (CKD) risk. Evidence Rating Level: 2 (Good) Sodium intake is essential for various physiological functions, but high consumption has been associated with hypertension and CKD. Self-reported frequency
Delayed in three hospitals by the pandemic and other technical reasons, expansion will add 773 beds at peripheral hospitals and bring in super speciality treatm